Microdosing & Exploring New Frontiers in Cancer Treatment w/Aneel Paulus

Aneel Paulus M.D. is a globally recognized drug developer having led a cancer drug development lab at the Mayo Clinic focused on treating the rarest forms of cancers including myeloma, leukemia, and lymphomas.

Determined to help those afflicted with cancer from every possible point of attack - Aneel has devoted himself to analyzing the mysteries of human aging, the complex neuroscience that undergirds cancer, and the potential application of psychedelic-assisted therapies for cancer patients battling existential depression.

Aneel Paulus is pioneering a new field he calls "cancer neuroscience," combining his lifelong fascination with neuroscience, his work in cancer drug development, and his personal experience with mindset and emotional resilience. His journey began with fundamental questions:

• How does cancer work?
• Why do we have cancer?
• What systems keep it in check, and what happens when they fail?

These inquiries, shaped by his hands-on care for cancer patients, revealed a striking insight—by the time most treatments are administered, it’s often too late.

Cancer doesn’t develop overnight; it can take years for that first rogue cell to bypass the body’s defenses, exploiting weaknesses in physiological, emotional, and mental systems.

Dr. Paulus’ work emphasizes immune therapies to strengthen the body’s defenses as a form of preventative care.

He’s uncovered how neurochemicals—feeding every cell in the body—are deeply influenced by factors like mindset, emotional and physical stress, nutrition, sleep, and relationships.

Stress, which significantly weakens the immune system, often stems from these interconnected areas, highlighting the critical role of holistic approaches in cancer prevention and care.

Connect with Aneel:

• Website
• LinkedIn